| Home | About Generics | Docs & Positions | Facts & Figures | Press Room | Conferences | Links |
Making Medicines affordable.News RoomLatest NewsPress ReleasesReleases 2007 Releases 2006 Releases 2005 Releases 2004 Releases 2003Media KitGenerics Industry |
EGA NewsWednesday, 2 March 2005“Thankful for Generics”EGA Reception in the European Parliament Mr Phillip Whitehead, MEP and Chairman of the Committee on Internal Market & Consumer Protection told a group of MEPs and members of EGA Board of Directors at a reception in the European Parliament that “We are thankful to the generic medicines industry for their contribution to bringing down pharmaceutical prices.” He urged MEPs to maintain their efforts to ensure that the generics industry can continue to meet the increasing demand in Europe for affordable medicines Emile Loof, President of EGA, emphasised the growing importance of low-cost generic medicines in the current healthcare equation that includes rising prices for originator pharmaceuticals, a rapidly aging population, and a deminishing work force supporting health insurance systems. Greg Perry, Director General, underscored the need to ensure a properly balanced competitive, regulatory and legal environment for the generics industry to continue meeting its commitment with European patients and healthcare systems. Critical to the industry is the full and correct implementation of the EU pharmaceutical legislation adopted in 2004. Photographs courtesy of the European Parliament Click on the thumbnails to see the full-sized photo.
<< Back |
The EGA“In an era when increasing demands are being made on Europe’s healthcare services, generic medicines provide a major benefit to society as they ensure patient access to quality, safe and effective medicines while reducing the cost of medicinal care.” The EGA is the official representative body of the European generic pharmaceuticals industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector. The EGA represents over 500 companies and their subsidiaries from greater Europe, and over 100,000 jobs. Generic medicines save €18 billion each year for health care systems and patients. For further information: About the EGA About Generics |
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
| Copyright © 2004 EGA - European Generic medicines Association • • Cascading Pop-up Menus ©Angus Turnbull |